SEQ ID NO: 1 from EP2716297B1

General Information


DCTPep ID  DCTPep01160

Peptide Name   SEQ ID NO: 1 from EP2716297B1

Sequence  LNQESARKSE

Sequence Length  10

UniProt ID  Not available

PubChem CID  Not available

Origin  Screen of phage display peptide library

Type  Native peptide

Classification

  

ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C46H80N16O19

Absent amino acids  CDFGHIMPTVWY

Theoretical pI  6.14

Acidic residues  2

Basic residues  2

Polar residues  3

Molecular weight (Average)  1161.24

Molecular weight (Monoisotopic)  1160.58

Common amino acids  ES

Net charge  0

Instability index (II)  59.24

Aliphatic index  49.00

Grand average of hydropathicity (GRAVY)  -1.840

Half Life 
  5.5 hours (mammalian reticulocytes, in vitro).
  3 min (yeast, in vivo).
  2 min (Escherichia coli, in vivo).

Extinction coefficients 
  Should not be visible by UV spectrophotometry.

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID EP2524926B1

Patent Title  Anticancer Peptide Sequence

Other Iinformation  Granted Patent; Family: 7s / 7ex; Family Jurisdictions: EP, KR, WO; Legal Status: Active; Application No: 10843287; Filed: Dec 27, 2010; Published: Mar 9, 2016; Earliest Priority: Jan 12, 2010; Granted: Mar 9, 2016

Other Published ID  EP2524926A4  EP2524926B1  KR101815322B1  KR20110082954A  WO2011087222A2  WO2011087222A3 




DCTPep is developed by Dr.Zheng's team.